NTR ApS: Financial statements 2023
CVR: 41551070
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NTR ApS (CVR 41551070) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,613,716 and a net result of DKK 1,576,533 compared with DKK 1,417,272 the year before. That is an increase of 30.4% compared with the year before. Equity in the 2023 report amounted to DKK 1,743,717. The solvency ratio was 67.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 6,613,716
- Profit/Loss
- DKK 1,576,533
- Equity
- DKK 1,743,717
- Total Assets
- DKK 2,587,751
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 6.6 mio. | 1.6 mio. | 1.7 mio. | 3 |
| 2022 | - | 5.1 mio. | 1.4 mio. | 917 t. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NTR ApS has published its annual report for 2022. Gross profit came to DKK 5,070,775, and the net result was DKK 1,417,272.
About NTR ApS
NTR ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of Robert Gabriel Coumine Riis and Thomas Frese Hasseriis. The company is owned by Diagnostix Holding ApS, Riis Medical Consulting ApS and TFH Medical Consulting ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 3,593,373 and a net result of DKK 1,190,585 compared with DKK 1,804,834 the year before. Equity in the 2025 report amounted to DKK 1,439,136.
